Deflazacort
- Product NDC
- 59651-599
- 11-digit product format
- 596510599
- Labeler code
- 59651
- Product ID
- 59651-599_dc2886e0-4e19-4a7c-b7ae-5723d7b4b8c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deflazacort
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA217123
- Marketing category
- ANDA
- Marketing start
- 2024-02-09
- Substance
- DEFLAZACORT
- Active strength
- 6 mg/1
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deflazacort
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFLAZACORT | 6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KR5YZ6AE4B |
| Rxcui | 153098, 153880, 1870954, 1870958 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-599-01 | Deflazacort | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-599 | DEFLAZACORT TABLET [AUROBINDO PHARMA LIMITED] | 2 | Current NDC, 1 package rows | 20240627_77d7525d-89c9-4fde-a6a8-0a463fd6cfeb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-599-01 | 59651059901 | 100 TABLET in 1 BOTTLE (59651-599-01) | 100 tablet | 2024-02-09 | No | No | Current |